Exploring the Future Treatment Landscape of Hepatocellular Carcinoma
Richard S. Finn, MD, discusses how he sees the field of hepatocellular carcinoma evolving in the future.
The Challenges of Treating Liver Cancer
Richard Finn, MD, from UCLA's Jonsson Comprehensive Cancer Center, discusses the difficulties of treating liver cancer.
Treating ER+ Breast Cancer Patients With Antiestrogens
Richard Finn, MD, from UCLA, discusses the treatment of patients with estrogen receptor-positive (ER+) breast cancer with antiestrogens.
Cyclin-Dependent Kinases and the Treatment of Cancer
Richard Finn, MD, from the Jonsson Comprehensive Cancer Center, UCLA, describes the development of cyclin-dependent kinases (CDKs) for the treatment of cancer.
The Future of Palbociclib for the Treatment of Breast Cancer
Richard Finn, MD, comments on the future of palbociclib (PD 0332991), a novel oral selective inhibitor of cyclin-dependent kinase 4/6 (CDK 4/6), for the treatment of breast cancer.